China's Healthcare Sector Accelerates Reform and Innovation: National Work Conference Sets 2026 Priorities, $840M in IT Tenders, AI Policies Surge, Medical Data Rules Tighten, and Brain-Computer Interface Firm Files IPO After $2.9B Funding
Neuralink
Brain-Computer Interface System Developer
Industry News
December 2025 Monthly Report on Hospital Construction: Progress of 55 Hospital Projects, A Wave of Year-End Openings and Topping-Out Ceremonies for Numerous Hospitals, ByteDance Acquires Land for Hospital Construction at a Cost of RMB 336 Million
In December 2025, China’s medical infrastructure construction concluded with an unprecedented year-end surge of facility inaugurations and topping-out ceremonies. National Regional Medical Centers were fully implemented, while large local general hospitals and specialized hospitals accelerated their capacity expansion. New functional spaces integrating traditional Chinese and Western medicine, dual-use facilities for both routine and emergency purposes, and combined rehabilitation and elderly care models continued to emerge. Medical infrastructure development is systematically shifting from “increasing quantity and expanding scale” to “enhancing capability levels and strengthening the system.”
On December 30, the “Launch of the National AI Application Pilot Base (Hefei) and Global Ecosystem Team Recruitment” conference was held in Hefei, officially marking the commencement of construction for the National AI Application Pilot Base (Hefei).According to reports,The base primarily focuses on primary healthcare services in the medical field., jointly promoted and implemented by Hefei Big Data Asset Operation Co., Ltd., industry-leading enterprises, and provincial and municipal medical institutions,Its core mission is to embed artificial intelligence technology at the grassroots level, substantially empowering frontline primary care diagnostics and treatment.
On December 31, 2025, at the “Beijing Health and Medical High-Quality Dataset Promotion Conference,” the Beijing Health Big Data and Policy Research Center launched"Technical Specifications for Anonymization of Health and Medical Data (Trial)". The Technical Specifications, spearheaded by the Big Data and Policy Research Center of the Beijing Municipal Health Commission, define technical standards and management requirements for the secure circulation of medical data, thereby establishing a robust institutional foundation to alleviate concerns among healthcare institutions and enterprises regarding participation in data trading and to ensure compliant data flows. This specificationBased on the characteristics of the health sector and practical operational needs, emphasis is placed on the core principle of balancing data value extraction with personal information protection.
Sichuan Province Announces First Batch of Typical Cases for “AI + Healthcare”
Recently,The General Office of the Sichuan Provincial Health Commission Announces the Province’s First Batch of Typical Cases for “Artificial Intelligence + Healthcare”A total of 18 typical cases from 16 institutions were selected, covering areas such as AI-enabled primary care applications, clinical diagnosis and treatment, patient services, traditional Chinese medicine, public health, and industry governance.
Musk Says Neuralink Brain-Computer Interface to Enter Mass Production This Year, with Fully Automated Surgery Being Advanced in Parallel
Elon Musk recently stated on the social media platform X that his brain-computer interface (BCI) company, Neuralink, will commence mass production of its BCI devices in 2026, while simultaneously advancing the full automation of its surgical procedures. Neuralink initiated human clinical trials in 2024, having previously addressed safety concerns raised by the U.S. Food and Drug Administration (FDA), which had rejected its initial application in 2022. The company disclosed that, as of last September, 12 patients with severe paralysis worldwide had received implants, enabling them to control digital devices and physical tools using their thoughts. Additionally, Neuralink secured $650 million in financing in June of the same year.
Industry News
December 2025 Monthly Report on Hospital Construction: Progress of 55 Hospital Projects, A Wave of Year-End Openings and Topping-Out Ceremonies for Numerous Hospitals, ByteDance Acquires Land for Hospital Construction at a Cost of RMB 336 Million
In December 2025, China’s medical infrastructure construction concluded with an unprecedented year-end surge of facility inaugurations and topping-out ceremonies. National Regional Medical Centers were fully implemented, while large local general hospitals and specialized hospitals accelerated their capacity expansion. New functional spaces integrating traditional Chinese and Western medicine, dual-use facilities for both routine and emergency purposes, and combined rehabilitation and elderly care models continued to emerge. Medical infrastructure development is systematically shifting from “increasing quantity and expanding scale” to “enhancing capability levels and strengthening the system.”
On December 30, the “Launch of the National AI Application Pilot Base (Hefei) and Global Ecosystem Team Recruitment” conference was held in Hefei, officially marking the commencement of construction for the National AI Application Pilot Base (Hefei).According to reports,The base primarily focuses on primary healthcare services in the medical field., jointly promoted and implemented by Hefei Big Data Asset Operation Co., Ltd., industry-leading enterprises, and provincial and municipal medical institutions,Its core mission is to embed artificial intelligence technology at the grassroots level, substantially empowering frontline primary care diagnostics and treatment.
On December 31, 2025, at the “Beijing Health and Medical High-Quality Dataset Promotion Conference,” the Beijing Health Big Data and Policy Research Center launched"Technical Specifications for Anonymization of Health and Medical Data (Trial)". The Technical Specifications, spearheaded by the Big Data and Policy Research Center of the Beijing Municipal Health Commission, define technical standards and management requirements for the secure circulation of medical data, thereby establishing a robust institutional foundation to alleviate concerns among healthcare institutions and enterprises regarding participation in data trading and to ensure compliant data flows. This specificationBased on the characteristics of the health sector and practical operational needs, emphasis is placed on the core principle of balancing data value extraction with personal information protection.
Sichuan Province Announces First Batch of Typical Cases for “AI + Healthcare”
Recently,The General Office of the Sichuan Provincial Health Commission Announces the Province’s First Batch of Typical Cases for “Artificial Intelligence + Healthcare”A total of 18 typical cases from 16 institutions were selected, covering areas such as AI-enabled primary care applications, clinical diagnosis and treatment, patient services, traditional Chinese medicine, public health, and industry governance.
Musk Says Neuralink Brain-Computer Interface to Enter Mass Production This Year, with Fully Automated Surgery Being Advanced in Parallel
Elon Musk recently stated on the social media platform X that his brain-computer interface (BCI) company, Neuralink, will commence mass production of its BCI devices in 2026, while simultaneously advancing the full automation of its surgical procedures. Neuralink initiated human clinical trials in 2024, having previously addressed safety concerns raised by the U.S. Food and Drug Administration (FDA), which had rejected its initial application in 2022. The company disclosed that, as of last September, 12 patients with severe paralysis worldwide had received implants, enabling them to control digital devices and physical tools using their thoughts. Additionally, Neuralink secured $650 million in financing in June of the same year.
Major Policy
Major Policy
2026 National Health Conference: Regulate the Scale and Growth Rate of Tertiary Hospitals, Vigorously Develop New Quality Productive Forces
From January 5 to 6, the National Health Work Conference was held in Beijing, systematically summarizing the achievements of health work in 2025 and during the “14th Five-Year Plan” period, and comprehensively deploying key tasks for 2026. The conference proposed optimizing the functional positioning and structure of medical institutions in accordance with the principle of “strengthening primary care, stabilizing secondary care, and controlling tertiary care.”Continuously advance the healthcare infrastructure strengthening initiative, stabilize the operations of secondary hospitals and expand their rehabilitation and nursing functions, regulate the scale and development pace of tertiary hospitals, and optimize their structure.Comprehensively enhance the public welfare nature, accessibility, and capacity of healthcare services. In addition, it willVigorously develop new quality productive forces in the health sector. Strengthen scientific and technological innovation in health, promote the transformation and application of scientific and technological achievements, advance digital and intelligent empowerment, and improve the mechanisms for training, incentivizing, and evaluating research personnel.Beijing Unveils Action Plan for Medical AI: Widespread Implementation of AI Applications in Hospitals Citywide by 2027, with 15 Measures to Build an Industrial Support System
On December 30, the Beijing Municipal Health Commission issued"Beijing Municipal Action Plan for Supporting the Development of Artificial Intelligence Applications in the Medical and Health Sector (2026-2027)"and"Several Measures to Support the Innovative Development of the Artificial Intelligence Industry in the Field of Medical Health in Beijing (2026-2027)."Propose to increase the digital and intelligent construction in the field of medical health,By 2027, awareness of digitalization and intelligence will be deeply ingrained in the healthcare sector. Artificial intelligence technologies will be widely applied across the entire continuum of disease prevention, screening, management, emergency care, treatment, and rehabilitation. Healthcare institutions throughout the city will universally implement AI-based products in clinical practice., increase effective supply, ensure safety and controllability, promote equitable access, and enable the general public to widely enjoy higher-quality, more convenient, and more efficient healthcare services.
National Healthcare Security Administration Releases “Guidelines”: Evaluation of Medical Software/AI-Driven Projects, with a Focus on Data Sources and Quality Control
On January 5, 2026, the National Healthcare Security Administration released a public consultation notice on the “Guidelines for the Management of Comprehensive Value Assessment of Medical Services in Real-World Settings for Health Insurance Coverage (Trial)”. The evaluation subjects are categorized into six types, among whichMedical Software/AI-Driven Projects refer to medical services that leverage medical software or artificial intelligence algorithmic models as the core driver, delivering diagnostic and therapeutic support or disease management through data integration, logical computation, pattern recognition, and decision support.The value of the service is reflected in improving diagnostic and treatment efficiency, optimizing judgment accuracy, or expanding service boundaries. Algorithm precision, data processing capabilities, and clinical adaptability constitute the core value of the service.
Eight Departments Issue Major “AI+” Policy Document: Accelerating Development of AI Pharmaceuticals, Intelligent Medical Equipment, and Brain-Computer Interfaces!
On January 8, 2026, the Ministry of Industry and Information Technology, the National Development and Reform Commission, and six other departments jointly issued the “Implementation Opinions on the ‘AI + Manufacturing’ Special Action,” proposingEnhance the intelligent R&D and supply chain management capabilities in the pharmaceutical industry.Build an AI-driven platform for novel drug discovery and virtual screening, leveraging multimodal large models for efficacy prediction to accelerate target identification and candidate drug discovery, thereby reducing the drug development cycle and costs. Integrate quantum chemistry simulations with artificial intelligence to precisely design drug molecular structures, enhancing efficacy and safety. Accelerate the implementation of AI in drug synthesis pathway planning and raw material combination optimization, establishing an automated, high-throughput, and cost-effective intelligent drug synthesis system.
National Healthcare Security Administration: Vigorously Promote Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment, with Nationwide Rollout by 2028
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
2026 National Health Conference: Regulate the Scale and Growth Rate of Tertiary Hospitals, Vigorously Develop New Quality Productive Forces
Beijing Unveils Action Plan for Medical AI: Widespread Implementation of AI Applications in Hospitals Citywide by 2027, with 15 Measures to Build an Industrial Support System
On December 30, the Beijing Municipal Health Commission issued"Beijing Municipal Action Plan for Supporting the Development of Artificial Intelligence Applications in the Medical and Health Sector (2026-2027)"and"Several Measures to Support the Innovative Development of the Artificial Intelligence Industry in the Field of Medical Health in Beijing (2026-2027)."Propose to increase the digital and intelligent construction in the field of medical health,By 2027, awareness of digitalization and intelligence will be deeply ingrained in the healthcare sector. Artificial intelligence technologies will be widely applied across the entire continuum of disease prevention, screening, management, emergency care, treatment, and rehabilitation. Healthcare institutions throughout the city will universally implement AI-based products in clinical practice., increase effective supply, ensure safety and controllability, promote equitable access, and enable the general public to widely enjoy higher-quality, more convenient, and more efficient healthcare services.
Beijing Unveils Action Plan for Medical AI: Widespread Implementation of AI Applications in Hospitals Citywide by 2027, with 15 Measures to Build an Industrial Support System
On December 30, the Beijing Municipal Health Commission issued"Beijing Municipal Action Plan for Supporting the Development of Artificial Intelligence Applications in the Medical and Health Sector (2026-2027)"and"Several Measures to Support the Innovative Development of the Artificial Intelligence Industry in the Field of Medical Health in Beijing (2026-2027)."Propose to increase the digital and intelligent construction in the field of medical health,By 2027, awareness of digitalization and intelligence will be deeply ingrained in the healthcare sector. Artificial intelligence technologies will be widely applied across the entire continuum of disease prevention, screening, management, emergency care, treatment, and rehabilitation. Healthcare institutions throughout the city will universally implement AI-based products in clinical practice., increase effective supply, ensure safety and controllability, promote equitable access, and enable the general public to widely enjoy higher-quality, more convenient, and more efficient healthcare services.
On December 30, the Beijing Municipal Health Commission issued"Beijing Municipal Action Plan for Supporting the Development of Artificial Intelligence Applications in the Medical and Health Sector (2026-2027)"and"Several Measures to Support the Innovative Development of the Artificial Intelligence Industry in the Field of Medical Health in Beijing (2026-2027)."Propose to increase the digital and intelligent construction in the field of medical health,By 2027, awareness of digitalization and intelligence will be deeply ingrained in the healthcare sector. Artificial intelligence technologies will be widely applied across the entire continuum of disease prevention, screening, management, emergency care, treatment, and rehabilitation. Healthcare institutions throughout the city will universally implement AI-based products in clinical practice., increase effective supply, ensure safety and controllability, promote equitable access, and enable the general public to widely enjoy higher-quality, more convenient, and more efficient healthcare services.
National Healthcare Security Administration Releases “Guidelines”: Evaluation of Medical Software/AI-Driven Projects, with a Focus on Data Sources and Quality Control
On January 5, 2026, the National Healthcare Security Administration released a public consultation notice on the “Guidelines for the Management of Comprehensive Value Assessment of Medical Services in Real-World Settings for Health Insurance Coverage (Trial)”. The evaluation subjects are categorized into six types, among whichMedical Software/AI-Driven Projects refer to medical services that leverage medical software or artificial intelligence algorithmic models as the core driver, delivering diagnostic and therapeutic support or disease management through data integration, logical computation, pattern recognition, and decision support.The value of the service is reflected in improving diagnostic and treatment efficiency, optimizing judgment accuracy, or expanding service boundaries. Algorithm precision, data processing capabilities, and clinical adaptability constitute the core value of the service.
Eight Departments Issue Major “AI+” Policy Document: Accelerating Development of AI Pharmaceuticals, Intelligent Medical Equipment, and Brain-Computer Interfaces!
On January 8, 2026, the Ministry of Industry and Information Technology, the National Development and Reform Commission, and six other departments jointly issued the “Implementation Opinions on the ‘AI + Manufacturing’ Special Action,” proposingEnhance the intelligent R&D and supply chain management capabilities in the pharmaceutical industry.Build an AI-driven platform for novel drug discovery and virtual screening, leveraging multimodal large models for efficacy prediction to accelerate target identification and candidate drug discovery, thereby reducing the drug development cycle and costs. Integrate quantum chemistry simulations with artificial intelligence to precisely design drug molecular structures, enhancing efficacy and safety. Accelerate the implementation of AI in drug synthesis pathway planning and raw material combination optimization, establishing an automated, high-throughput, and cost-effective intelligent drug synthesis system.
National Healthcare Security Administration: Vigorously Promote Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment, with Nationwide Rollout by 2028
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
On January 5, 2026, the National Healthcare Security Administration released a public consultation notice on the “Guidelines for the Management of Comprehensive Value Assessment of Medical Services in Real-World Settings for Health Insurance Coverage (Trial)”. The evaluation subjects are categorized into six types, among whichMedical Software/AI-Driven Projects refer to medical services that leverage medical software or artificial intelligence algorithmic models as the core driver, delivering diagnostic and therapeutic support or disease management through data integration, logical computation, pattern recognition, and decision support.The value of the service is reflected in improving diagnostic and treatment efficiency, optimizing judgment accuracy, or expanding service boundaries. Algorithm precision, data processing capabilities, and clinical adaptability constitute the core value of the service.
On January 5, 2026, the National Healthcare Security Administration released a public consultation notice on the “Guidelines for the Management of Comprehensive Value Assessment of Medical Services in Real-World Settings for Health Insurance Coverage (Trial)”. The evaluation subjects are categorized into six types, among whichMedical Software/AI-Driven Projects refer to medical services that leverage medical software or artificial intelligence algorithmic models as the core driver, delivering diagnostic and therapeutic support or disease management through data integration, logical computation, pattern recognition, and decision support.The value of the service is reflected in improving diagnostic and treatment efficiency, optimizing judgment accuracy, or expanding service boundaries. Algorithm precision, data processing capabilities, and clinical adaptability constitute the core value of the service.
Eight Departments Issue Major “AI+” Policy Document: Accelerating Development of AI Pharmaceuticals, Intelligent Medical Equipment, and Brain-Computer Interfaces!
On January 8, 2026, the Ministry of Industry and Information Technology, the National Development and Reform Commission, and six other departments jointly issued the “Implementation Opinions on the ‘AI + Manufacturing’ Special Action,” proposingEnhance the intelligent R&D and supply chain management capabilities in the pharmaceutical industry.Build an AI-driven platform for novel drug discovery and virtual screening, leveraging multimodal large models for efficacy prediction to accelerate target identification and candidate drug discovery, thereby reducing the drug development cycle and costs. Integrate quantum chemistry simulations with artificial intelligence to precisely design drug molecular structures, enhancing efficacy and safety. Accelerate the implementation of AI in drug synthesis pathway planning and raw material combination optimization, establishing an automated, high-throughput, and cost-effective intelligent drug synthesis system.
National Healthcare Security Administration: Vigorously Promote Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment, with Nationwide Rollout by 2028
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
Eight Departments Issue Major “AI+” Policy Document: Accelerating Development of AI Pharmaceuticals, Intelligent Medical Equipment, and Brain-Computer Interfaces!
On January 8, 2026, the Ministry of Industry and Information Technology, the National Development and Reform Commission, and six other departments jointly issued the “Implementation Opinions on the ‘AI + Manufacturing’ Special Action,” proposingEnhance the intelligent R&D and supply chain management capabilities in the pharmaceutical industry.Build an AI-driven platform for novel drug discovery and virtual screening, leveraging multimodal large models for efficacy prediction to accelerate target identification and candidate drug discovery, thereby reducing the drug development cycle and costs. Integrate quantum chemistry simulations with artificial intelligence to precisely design drug molecular structures, enhancing efficacy and safety. Accelerate the implementation of AI in drug synthesis pathway planning and raw material combination optimization, establishing an automated, high-throughput, and cost-effective intelligent drug synthesis system.
National Healthcare Security Administration: Vigorously Promote Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment, with Nationwide Rollout by 2028
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
On January 8, 2026, the Ministry of Industry and Information Technology, the National Development and Reform Commission, and six other departments jointly issued the “Implementation Opinions on the ‘AI + Manufacturing’ Special Action,” proposingEnhance the intelligent R&D and supply chain management capabilities in the pharmaceutical industry.Build an AI-driven platform for novel drug discovery and virtual screening, leveraging multimodal large models for efficacy prediction to accelerate target identification and candidate drug discovery, thereby reducing the drug development cycle and costs. Integrate quantum chemistry simulations with artificial intelligence to precisely design drug molecular structures, enhancing efficacy and safety. Accelerate the implementation of AI in drug synthesis pathway planning and raw material combination optimization, establishing an automated, high-throughput, and cost-effective intelligent drug synthesis system.
National Healthcare Security Administration: Vigorously Promote Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment, with Nationwide Rollout by 2028
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
National Healthcare Security Administration: Vigorously Promote Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment, with Nationwide Rollout by 2028
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
On January 8, the National Healthcare Security Administration issued the “Notice on Vigorously Promoting Convenient Payment Methods Including Facial Recognition Payment, Unified Code Payment, Mobile Payment, and Credit-Based Payment.” It proposed advancing the development of a convenient payment system in which facial recognition payment, unified code payment, mobile payment, and credit-based payment are integrated and mutually complementary.The application scenarios cover outpatient and emergency services, as well as inpatient care, with the goal of fully establishing a secure, convenient, efficient, and mature medical insurance payment system within approximately three years.Provincial-level healthcare security administrations shall prioritize cities with robust information technology infrastructure, strong willingness among medical institutions to undergo reform, and favorable financial cooperation environments for solid implementation. In principle, each province shall select no fewer than two cities for the initial phase of implementation. Each province is required to ensure that the initial pilot regions and designated medical institutions achieve tangible results by 2026, basically achieve full coverage across all pooled insurance areas within the province by 2027, and comprehensively roll out the program to all eligible designated medical institutions within the province by 2028.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
Beijing: Support the Construction of Pilot-Scale Test Platforms for Industries Including Pharmaceuticals and Healthcare, with Subsidies Up to RMB 100 Million
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
On January 4, the Beijing Municipal Development and Reform Commission, the Municipal Bureau of Economy and Information Technology, and the Municipal Science and Technology Commission/Zhongguancun Administrative Committee jointly issued“Several Measures on Further Enhancing the City’s Pilot-Scale Testing Service Capabilities to Promote the Integrated Development of Scientific and Technological Innovation and Industrial Innovation”(hereinafter referred to as the “Several Measures”), proposesStrive to establish 10 national-level pilot-scale manufacturing platforms in Beijing by 2030, and support the construction of 50 municipal-level pilot-scale platforms.In Artificial Intelligence,Pharmaceuticals and Healthcare, green and low-carbon industries, robotics and intelligent manufacturing as internationally leading sectors; new materials, integrated circuits, aerospace technology, and emerging safety and emergency response as foundational and security-strengthening industries; and the growth matrix of future industries,Establish a number of pilot-scale platforms, and provide subsidy support for new construction projects that meet the municipal government's fixed asset investment support criteria, at 35% of the total project investment, with a maximum cap of RMB 100 million.
Tender for Medical Informatics Project
Baishan City Public Hospital Reform and High-Quality Development Demonstration Project Information Technology Construction Project
On December 30, 2025, the Baishan Municipal Health Commission released the "Government Procurement Intentions for January to April 2026." The project involves the construction of the Baishan Municipal Health Information System Platform, creating a new model of the "Seven Ones" smart healthcare system: one network, one medical cloud, one platform, one health data center, integrated applications (medical care, regional health, and medical consortia), one standard system, and unified operations and maintenance, thereby establishing a digital medical cloud platform that integrates integration, digitization, networking, and intelligence.Budget Amount:RMB 124,950,000.Estimated Procurement Time:February 2026.
On January 5, the Yanling County Health Commission released the “Procurement Intentions for Government Purchases from January to September 2026.”Procurement RequirementsIncluding informatization of medical consortia, integrated construction of in-hospital information systems, and procurement of supporting hardware equipment and related services. Pre-Calculate Amount:12,40010,000 yuan。Estimated Procurement Time:February 2026.
Mile City People's Hospital Smart Healthcare Information System Engineering Construction Project
On January 7, 2026, Mile City People's Hospital released the "Smart Medical Information System Engineering Construction Project" tenderBidding Announcement, requiring the submission of bid documents before 09:30 (Beijing Time) on January 29, 2026. The project requires the construction of an information technology infrastructure for Mile City People's Hospital, comprising a Hospital Information Platform, Smart Healthcare Platform, Smart Service Platform, and Smart Management Platform, to comprehensively support the hospital’s development in clinical care, scientific research, teaching, and operational management.Budget Amount:8464.996410,000 yuan.
Changping District Municipal Medical Institutions Integrated Information Platform Project
On December 26, the Health Commission of Changping District, Beijing, released the "Public Tender Announcement for the Integrated Information Platform Project of Changping District-Affiliated Medical Institutions." The project covers public medical and health institutions in Changping District, with a focus on advancing the construction of the "124" core architecture. Potential bidders shall obtain the tender documents from the Beijing Government Procurement Electronic Trading Platform and submit their bids no later than 09:00 (Beijing Time) on January 16, 2026.Budget Amount:RMB 64.6725762 million.
Information Technology Capability Enhancement Service Project of the People's Hospital of Qianxinan Buyi and Miao Autonomous Prefecture
On January 4, 2026, the People's Hospital of Qianxinan Buyei and Miao Autonomous Prefecture released a public notice outlining the requirements for the "Hospital Information Capability Enhancement Service Project." The project aims to benchmark against the informatization practices, real-world application performance, and outcomes of leading domestic hospitals, thereby rapidly elevating the level of informatization in medical services and hospital management, and maximizing the localized implementation of smart healthcare and smart management solutions. The budget is RMB 37,500,000.
Healthcare Improvement Project Across Wengyuan County, Shaoguan City, Guangdong Province – IT Construction Project for the Resource Sharing Center of the Close-knit County-level Medical Community in Wengyuan County
On January 5, 2026, the Wengyuan County Health Bureau issued a notice soliciting public comments on the procurement requirements for the "Wengyuan County Tight-Knit County-Level Medical Community Resource Sharing Center Informationization Construction Project" under the "Wengyuan County Comprehensive Healthcare Improvement Project" in Shaoguan City, Guangdong Province, with a budget of RMB 36.9218 million.
Yunnan Provincial Hospital of Traditional Chinese Medicine (Yunnan Provincial Ethnic Medicine Hospital) Smart Hospital Information System Construction Project
On December 30, 2025, the Yunnan Provincial Hospital of Traditional Chinese Medicine issued a tender announcement for the “Smart Hospital Information System Upgrade and Renovation Project—Yunnan Provincial Hospital of Traditional Chinese Medicine (Yunnan Provincial Ethnic Medicine Hospital) Smart Hospital Information System Construction Project,” with a budget of RMB 30,000,000.
Quzhou City Public Hospital Reform and High-Quality Development Demonstration Project – Kecheng District Health Service Consortium Smart Healthcare Informatics Enhancement Construction Project
On January 4, 2026, the People's Hospital of Kecheng District, Quzhou City, released the "First Government Procurement Intention for January 2026." The main function or objective to be achieved is the enhancement and construction of smart healthcare information systems for the Kecheng District Health Service Consortium. The estimated procurement time is March 2026. The budget amount is RMB 26,000,000.
Smart Hospital Construction Project of Yingcheng Traditional Chinese Medicine Hospital, Xiaogan City
On January 3, 2026, Yingcheng Hospital of Traditional Chinese Medicine in Xiaogan City released a procurement announcement for the "Smart Hospital Construction Project of Yingcheng Hospital of Traditional Chinese Medicine, Xiaogan City," with a budget of RMB 23.73133452 million. The project is divided into three parts: software development, hardware supporting equipment, and cloud resource leasing. The software development involves custom-built solutions. As this project belongs to the specialized healthcare sector, relevant policies stipulate that, in principle, the software system development process should adopt development methods compliant with the national localization substitution policy, and the hardware equipment purchased for this project should, in principle, be domestically produced provided it meets operational requirements. Cloud resource leasing constitutes a service acquisition and does not involve localization substitution. In summary, the design and implementation of this project are required to fulfill localization-related requirements to the greatest extent possible, thereby facilitating subsequent system iterations toward full localization.
Construction of the New-Generation Big Data Platform (Phase I) at the First Affiliated Hospital of Chongqing Medical University
On January 7, 2026, the First Affiliated Hospital of Chongqing Medical University released the "Government Procurement Intentions for March 2026."**Target Objective:** To establish a unified hospital-wide big data platform, aggregate comprehensive hospital data into a data lake, and build a system for data acquisition, governance, and quality control to implement specialized and thematic data governance. Improve the construction of the data middle platform, develop data assetization components, and form unified, accessible data assets across the hospital, thereby providing standardized, secure, and convenient data openness capabilities for internal applications. Construct a big data and AI application system oriented towards hospital management, clinical services, and scientific research.Budget Amount: RMB 23 million. Estimated Procurement Time: March 2026.
Information Technology Infrastructure Enhancement Project for the Capacity Building of the Binzhou People’s Medical and Health General Hospital’s Integrated Medical Consortium
Binzhou People's Medical Health General Hospital Close-knit Medical Consortium Capacity Enhancement Project - Information System Construction Enhancement Project (Second Round)Potential bidders for the tender shallRoom 1806, 18th Floor, Building 10, Daqin Yugangcheng, Qinhuang South Road, Qindu District, Xianyang CityObtain the bidding documents, and byJanuary 26, 2026 09:30(Beijing Time) before the deadline for bid submission. Budget amount: RMB 19,252,648.69.
Lease of Cloud Platform Infrastructure Disaster Recovery Center B for the Construction Project of the Medical Security Information Platform of the Heilongjiang Provincial Medical Security Bureau
Leasing of Cloud Platform Infrastructure Disaster Recovery Center B for the Provincial Medical Insurance Bureau's Medical Security Information Platform Construction ProjectPotential suppliers for the procurement project shall be atHeilongjiang Provincial Government Procurement NetworkObtain the procurement documents, and byJanuary 13, 2026 09:00(Beijing Time) submit the response documents. Budget amount: 7.4335 million yuan.
2025 Napo County Medical Community Informationization Construction Project
2025 Napo County Medical Community Informatics Construction ProjectPotential bidders for the tender project shallGuangxi Government Procurement Cloud Platform (https://www.gcy.zfcg.gxzf.gov.cn/)Obtain the tender documents, and byJanuary 26, 2026 09:00(Beijing Time) prior to the submission of bid documents. Total budget amount: RMB 4.57 million.
Huian County Hospital of Traditional Chinese Medicine Mobile Medical Insurance Payment and Payment Platform Upgrade Project
The Huian County Hospital of Traditional Chinese Medicine is conducting an open tender for the Mobile Medical Insurance Payment and Payment Platform Upgrade Project. Potential bidders shall obtain the procurement documents from the Fujian Provincial Government Procurement Network (zfcg.czt.fujian.gov.cn) and submit their bids byJanuary 29, 2026 09:30:00(Beijing Time) before the deadline for bid submission. Budget amount: RMB 1,994,950.00.
Construction of Guizhou Off-site Imaging Cache and Backup Center and National Healthcare Security Administration Disaster Recovery Center Project
Potential bidders for the Construction of Guizhou Off-site Image Caching and Backup Center and the National Healthcare Security Administration Disaster Recovery Center Project shall obtain documents online from the Guizhou Public Resources Trading Center (website of the Trading Center:https://ggzy.guizhou.gov.cn/hallweb/) Obtain the bidding documents and submit the bid files before 09:30:00 on January 27, 2026 (Beijing Time). Budget amount: RMB 1.933 million.
Procurement Project for the Phase I Clinical Trial Informatics Management Platform of the Affiliated Hospital of Xuzhou Medical University
Potential bidders for the procurement project of the Phase I Clinical Trial Informatics Management Platform at the Affiliated Hospital of Xuzhou Medical University shallhttp://www.jocxz.com/bidder"Obtain the bidding documents and submit the bid documents before 14:30 (Beijing Time) on January 28, 2026. Budget amount: 1.8 million yuan."
Intelligent Auxiliary Handling Project for Medical Insurance
Potential bidders for the intelligent auxiliary handling project of medical insurance shall obtain the bidding documents online from the Guizhou Provincial Public Resource Trading Center (website of the trading center:https://ggzy.guizhou.gov.cn/hallweb/) Obtain the bidding documents and submit the bid documents before 09:30:00 on January 27, 2026 (Beijing Time). Budget amount: RMB 1.6158 million.
Qingyang People's Hospital Procurement Project for the Medical Insurance Diagnosis and Treatment Item Billing Supervision System
Potential bidders for the second public tender of the Procurement Project for the Medical Insurance Diagnosis and Treatment Item Billing Supervision System at Qingyang People's Hospital in 2025 shall log in to the Qingyang Public Resources Trading Center Website – City-County Integrated System to obtain the public bidding documents free of charge, and submit their bid documents before 9:00 a.m. (Beijing Time) on January 29, 2026. The budget amount is RMB 1.48 million.
Procurement Project for the Construction of Changchun City's Medical Insurance Data Zone
Potential suppliers for the procurement project of constructing the Changchun Medical Insurance Data Zone shall visit the Changchun Public Resource Trading Network (URL:https://www.ccggzy.com.cn/) Obtain the procurement documents and submit the response documents before 09:30 (Beijing Time) on January 19, 2026. Budget amount: RMB 1.4 million.
Yongsheng County Information Technology Construction Project for the Central Pharmacy of the Close-Knit County-Level Medical Consortium
Potential bidders for the Yongsheng County Compact County-level Medical Consortium Central Pharmacy Information System Construction Project shall register on the Yunnan Provincial Government Procurement Electronic Trading Platform (Zhengcaiyun)https://www.zcygov.cn/) Obtain the bidding documents online and submit the bid documents before 09:30 (Beijing Time) on January 29, 2026. Budget amount: RMB 1.2 million.
Huidong County Maternal and Child Health Hospital: Medical Insurance Mobile Payment, Dual-Channel, and Other Interface and System Upgrade Project
Huidong County Maternal and Child Health Care Hospital: Medical Insurance Mobile Payment, Dual-Channel Interface, and System Renovation ProjectPotential suppliers shallGuangdong Provincial Government Procurement Networkhttps://gdgpo.czt.gd.gov.cn/Obtain the procurement documents, and byJanuary 20, 2026, 09:30(Beijing Time) before submitting the response documents. Budget amount: 1.03 million yuan.
Investment and Financing Updates
Insilico Medicine Lists on the Hong Kong Stock Exchange
On December 30, Insilico Medicine, a clinical-stage biopharmaceutical technology company powered by generative artificial intelligence, was listed on the Hong Kong Stock Exchange (HKEX), becoming the first AI-driven biopharmaceutical technology company to be listed under Rule 8.05 of the HKEX Main Board Listing Rules. The initial public offering (IPO) raised a total of HK$2.277 billion, marking the largest biopharmaceutical IPO on the Hong Kong stock market in 2025 in terms of funds raised.
BrainCo Completes RMB 2 Billion Financing
On January 8, 2026, Hangzhou BrainCo Technology confirmed the completion of approximately RMB 2 billion in financing. This round of funding will be used to accelerate the research and development of brain-computer interface (BCI) technology, achieve engineering breakthroughs, and scale up mass production of its products. The company plans to help one million individuals with limb disabilities regain their independence and reintegrate into society through neurally controlled prosthetics over the next five to ten years, thereby promoting the development of rehabilitation technology in China.
Edge Medical's Hong Kong Stock Listing
On January 8, 2026, Edge Medical Robotics (stock code: 02675), a leading Chinese surgical robotics company, was listed on the Hong Kong Stock Exchange, becoming the third domestic surgical robotics enterprise to enter the secondary market.As the first company in China and the second globally to master the core technologies of both multi-port (MP1000) and single-port (SP1000) laparoscopic surgical robots and receive NMPA approval, Edge Medical Robotics is a benchmark enterprise in the field of minimally invasive surgical robotics, positioned against Intuitive Surgical of the United States, and has successfully achieved domestic substitution for the da Vinci Surgical System. Internationally, the MP1000 has obtained regulatory approval in 14 overseas jurisdictions across Europe, Asia-Pacific, the Middle East, Africa, and South America.
Buffalo Robotics Secures Strategic Investment
On January 5, 2026, Buffalo Robot Technology (Chengdu) Co., Ltd., a developer of exoskeleton robots for rehabilitation medicine, announced the completion of strategic investment from Chengdu Science and Technology Service Group. This investment aims to support Buffalo Robot in further advancing the research and development and market application of rehabilitation medical exoskeleton robots.
Buffalo Robotics Secures Strategic Investment
On January 5, 2026, Buffalo Robot Technology (Chengdu) Co., Ltd., a developer of exoskeleton robots for rehabilitation medicine, announced the completion of strategic investment from Chengdu Science and Technology Service Group. This investment aims to support Buffalo Robot in further advancing the research and development and market application of rehabilitation medical exoskeleton robots.
Weijing Medical Robot Completes Hundreds of Millions in Series B+ Financing
On December 31, Hangzhou Kangji Weijing Medical Robot Co., Ltd. announced the completion of its B+ round financing, amounting to hundreds of millions of yuan. This round received exclusive investment from Guotai Junan Innovation Investment Co., Ltd., a subsidiary of Guotai Haitong Securities. Meanwhile, strategic shareholder Kangji Medical continued to increase its investment. Gelu Capital served as the exclusive financial advisor for this transaction.
Weijing Medical Robot Completes Hundreds of Millions in Series B+ Financing
On December 31, Hangzhou Kangji Weijing Medical Robot Co., Ltd. announced the completion of its B+ round financing, amounting to hundreds of millions of yuan. This round received exclusive investment from Guotai Junan Innovation Investment Co., Ltd., a subsidiary of Guotai Haitong Securities. Meanwhile, strategic shareholder Kangji Medical continued to increase its investment. Gelu Capital served as the exclusive financial advisor for this transaction.
Shurui Robotics Completes $100 Million Financing Round
On January 5, 2026, Beijing Surgerii Robotics Co., Ltd. announced the completion of a $100 million financing round, led by Loyal Valley Capital, with participation from investors including the Shanghai Biomedical Industry Equity Investment Fund. The proceeds from this round will be used to advance the clinical application of its products across multiple specialties both domestically and internationally, promote market expansion, and support the research and development of next-generation products. Founded in 2014, Surgerii Robotics specializes in the development of minimally invasive surgical robot systems. Its single-port surgical robot received approval for market launch from the National Medical Products Administration (NMPA) in 2023 and obtained European Union CE certification in 2025, becoming the first Chinese surgical robot approved for use in the general population in the EU. The company completed its IPO tutoring registration with the Beijing Bureau of the China Securities Regulatory Commission on December 2, with CITIC Securities serving as the tutoring institution.
Shurui Robotics Completes $100 Million Financing Round
On January 5, 2026, Beijing Surgerii Robotics Co., Ltd. announced the completion of a $100 million financing round, led by Loyal Valley Capital, with participation from investors including the Shanghai Biomedical Industry Equity Investment Fund. The proceeds from this round will be used to advance the clinical application of its products across multiple specialties both domestically and internationally, promote market expansion, and support the research and development of next-generation products. Founded in 2014, Surgerii Robotics specializes in the development of minimally invasive surgical robot systems. Its single-port surgical robot received approval for market launch from the National Medical Products Administration (NMPA) in 2023 and obtained European Union CE certification in 2025, becoming the first Chinese surgical robot approved for use in the general population in the EU. The company completed its IPO tutoring registration with the Beijing Bureau of the China Securities Regulatory Commission on December 2, with CITIC Securities serving as the tutoring institution.
Benkuo Technology Completes RMB 40 Million Angel Round Financing
Benkuo Technology is a developer of integrated medical training platforms. Centered on “integrated technology + scenario-based training,” it provides intelligent teaching, simulated clinical practice, and interdisciplinary collaboration platforms for universities and healthcare institutions. Its self-developed integrated training system integrates clinical data, virtual simulation, and AI-assisted decision-making capabilities, facilitating the cultivation of multidisciplinary medical talent. Recently, Benkuo Technology completed a RMB 40 million angel financing round. The funds from this round will be primarily allocated to the research and development of integrated training platforms for the university healthcare sector, market expansion, and team building.
Benkuo Technology Completes RMB 40 Million Angel Round Financing
Benkuo Technology is a developer of integrated medical training platforms. Centered on “integrated technology + scenario-based training,” it provides intelligent teaching, simulated clinical practice, and interdisciplinary collaboration platforms for universities and healthcare institutions. Its self-developed integrated training system integrates clinical data, virtual simulation, and AI-assisted decision-making capabilities, facilitating the cultivation of multidisciplinary medical talent. Recently, Benkuo Technology completed a RMB 40 million angel financing round. The funds from this round will be primarily allocated to the research and development of integrated training platforms for the university healthcare sector, market expansion, and team building.
Jiucheng Zhixiang Completes RMB 10 Million Angel Round Financing
Jiucheng Zhixiang is a developer of smart medical hardware products, focusing on smart ward application scenarios, including the construction of smart wards and big health industrial parks, iterative upgrades of smart shared companion care hardware, product line upgrades of smart infusion chairs, and the development of intelligent software systems for patient escort and nursing services. Recently, Jiucheng Zhixiang completed an angel round of financing amounting to RMB 10 million.
Jiucheng Zhixiang Completes RMB 10 Million Angel Round Financing
Jiucheng Zhixiang is a developer of smart medical hardware products, focusing on smart ward application scenarios, including the construction of smart wards and big health industrial parks, iterative upgrades of smart shared companion care hardware, product line upgrades of smart infusion chairs, and the development of intelligent software systems for patient escort and nursing services. Recently, Jiucheng Zhixiang completed an angel round of financing amounting to RMB 10 million.
Dugong Intelligence Secures Tens of Millions in Series A Funding
Dugong Intelligence, an integrated smart solution provider combining AI, IoT, and big health devices, has developed the Health Management Early Warning System AI Probes V1.0, achieving the commercialization of its intelligent products. Recently, Dugong Intelligence completed tens of millions of RMB in Series A financing. This round was led by Guangzhou Health Industry Investment Fund, with Shangji Transformation serving as the financial advisor. The funding will provide strong momentum for the market promotion of the company's core products and the diversification of its product pipeline, accelerating the adoption of weak magnetic medical technology to benefit more patients.
Dugong Intelligence Secures Tens of Millions in Series A Funding
Dugong Intelligence, an integrated smart solution provider combining AI, IoT, and big health devices, has developed the Health Management Early Warning System AI Probes V1.0, achieving the commercialization of its intelligent products. Recently, Dugong Intelligence completed tens of millions of RMB in Series A financing. This round was led by Guangzhou Health Industry Investment Fund, with Shangji Transformation serving as the financial advisor. The funding will provide strong momentum for the market promotion of the company's core products and the diversification of its product pipeline, accelerating the adoption of weak magnetic medical technology to benefit more patients.
Muguang Medical Completes Tens of Millions in Pre-A Round Financing
On January 9, 2026, Muguang Medical, a medical robotics company, announced the completion of its Pre-A financing round, raising tens of millions of yuan. The round was jointly invested by Huihe Asset Management, Xiamen Heguang Tongchuang, and other investors. The funds will be primarily used to advance product registration, accelerate the research and development of medical robots currently under development, and promote the market expansion of existing products. Muguang Medical specializes in the research and development, manufacturing, and sales of medical robots, committed to providing advanced technological support for the healthcare sector. This financing will help the company further enhance its innovation capabilities, accelerate commercialization, and drive innovative development in the medical device industry.
Muguang Medical Completes Tens of Millions in Pre-A Round Financing
On January 9, 2026, Muguang Medical, a medical robotics company, announced the completion of its Pre-A financing round, raising tens of millions of yuan. The round was jointly invested by Huihe Asset Management, Xiamen Heguang Tongchuang, and other investors. The funds will be primarily used to advance product registration, accelerate the research and development of medical robots currently under development, and promote the market expansion of existing products. Muguang Medical specializes in the research and development, manufacturing, and sales of medical robots, committed to providing advanced technological support for the healthcare sector. This financing will help the company further enhance its innovation capabilities, accelerate commercialization, and drive innovative development in the medical device industry.
Zhejiang Xiangyu Digital Intelligence Healthcare Secures RMB 2 Million in Financing
Recently, Zhejiang Xiangyu Digital Intelligence Medical Co., Ltd. successfully completed an early-stage funding round of RMB 2 million.Financing. This round of financing will support the company's technological research and development in the field of digital and intelligent operational services for health management,MarketBusiness expansion and team building have injected new momentum, marking the acceleration of its development in the medical technology sector.
Zhejiang Xiangyu Digital Intelligence Healthcare Secures RMB 2 Million in Financing
Recently, Zhejiang Xiangyu Digital Intelligence Medical Co., Ltd. successfully completed an early-stage funding round of RMB 2 million.Financing. This round of financing will support the company's technological research and development in the field of digital and intelligent operational services for health management,MarketBusiness expansion and team building have injected new momentum, marking the acceleration of its development in the medical technology sector.
Xiaozhu Sleep Completes Multi-Million Angel Financing Round
Recently,Beijing Xiaozhu Sleep Technology Co., Ltd.Announces Completion of Multi-Million Angel Financing Round. The funds raised in this round will be primarily used to upgrade the professional service system, expand the team, and broaden market reach, thereby further strengthening the company’s comprehensive service capabilities in the field of digital and intelligent sleep medicine.
Xiaozhu Sleep Completes Multi-Million Angel Financing Round
Recently,Beijing Xiaozhu Sleep Technology Co., Ltd.Announces Completion of Multi-Million Angel Financing Round. The funds raised in this round will be primarily used to upgrade the professional service system, expand the team, and broaden market reach, thereby further strengthening the company’s comprehensive service capabilities in the field of digital and intelligent sleep medicine.
Huaibei Huajian Technology or Strategic Investment
On January 7, 2026, CICC Investment announced the completion of its strategic investment in Huaibei Huajian Technology Co., Ltd. (hereinafter referred to as “Huaibei Huajian Technology”). This investment aims to support Huaibei Huajian Technology’s innovation and development in the field of smart health, and to further advance the implementation of its digital health service platform.
Huaibei Huajian Technology or Strategic Investment
On January 7, 2026, CICC Investment announced the completion of its strategic investment in Huaibei Huajian Technology Co., Ltd. (hereinafter referred to as “Huaibei Huajian Technology”). This investment aims to support Huaibei Huajian Technology’s innovation and development in the field of smart health, and to further advance the implementation of its digital health service platform.
BioBeat Secures $50 Million in Series B Funding
Biobeat has developed a cutting-edge wearable monitor for remote, non-invasive, accurate, medical-grade monitoring of vital signs and other medically relevant parameters. Recently, Biobeat completed a $50 million Series B financing round, co-led by new investors Ally Bridge Group, OrbiMed Advisors, and Elevage Medical, with participation from strategic investors.
BioBeat Secures $50 Million in Series B Funding
Biobeat has developed a cutting-edge wearable monitor for remote, non-invasive, accurate, medical-grade monitoring of vital signs and other medically relevant parameters. Recently, Biobeat completed a $50 million Series B financing round, co-led by new investors Ally Bridge Group, OrbiMed Advisors, and Elevage Medical, with participation from strategic investors.
[AI Computing Power + Application Discussion Community]
Invitation Only
Seats Being Locked: Exclusive Circle for Top-Tier Practitioners in AI Computing Power and AI Application Fields
√Access Hot Topics in Medical AI Applications and Exclusive Insights on Cutting-Edge Industry Developments
√Stay Updated on the Latest Regulatory and Policy Developments in Global Medical AI
√In-Depth Dialogue with Upstream and Downstream AI Enterprises
√Get First-Hand Global AI and Computing Power Industry Information
√Opportunity to participate in AI-themed industry exchange activities
Scan the QR code and include the keyword [AI Join Group] Add Friend
Verify Identity (SendName/Company/Job Title）
Share
Add to Favorites
Like
